Search research articles
Contact Us
Filters
Showing results (41-50 of 117) with videos related to
Page
of 12
Sort By:
Journal of Gastroenterology
|
November 15, 2024
Clinical factors to predict changes of esophagogastric varices after sustained viral response with direct-acting antiviral therapy
Takao Watanabe, Yoshio Tokumoto, Hironori Ochi, et al.
Scientific Reports
|
June 2, 2023
Simple new clinical score to predict hepatocellular carcinoma after sustained viral response with direct-acting antivirals
Takao Watanabe, Yoshio Tokumoto, Kouji Joko, et al.
Hepatology Communications
|
August 29, 2025
Carbon-ion radiotherapy achieves outcomes equivalent to surgical resection for hepatocellular carcinoma
Takeshi Hatanaka, Kei Shibuya, Satoru Kakizaki, et al.
Cancers
|
November 26, 2022
Comparison of Surgical Resection and Percutaneous Ultrasonographic Guided Radiofrequency Ablation for Initial Recurrence of Hepatocellular Carcinoma in Early Stage following Curative Treatment
Hideko Ohama, Atsushi Hiraoka, Fujimasa Tada, et al.
Oncology
|
July 17, 2023
Usefulness of aMAP Risk Score for Predicting Recurrence after Curative Treatment for Hepatocellular Carcinoma within Milan Criteria
Hideko Ohama, Atsushi Hiraoka, Fujimasa Tada, et al.
BMC Gastroenterology
|
November 14, 2025
Factors associated with ulcerative colitis with non-anemic iron deficiency
Shogo Kitahata, Mai Fukumoto, Kana Matsuoka, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology
|
September 23, 2022
The beneficial impact of metabolic dysfunction-associated fatty liver disease on lenvatinib treatment in patients with non-viral hepatocellular carcinoma
Shigeo Shimose, Atsushi Hiraoka, Andrea Casadei-Gardini, et al.
Oncology
|
August 20, 2024
Factors Affecting an Increase in Spleen Volume and Association of Spleen Volume Variation with the Clinical Outcomes of Atezolizumab and Bevacizumab Treatment for Hepatocellular Carcinoma: A Retrospective Analysis
Takeshi Hatanaka, Naoto Saito, Satoru Kakizaki, et al.
Oncology
|
October 11, 2023
Simple Scoring System for Esophagogastric Varices Prediction in Hepatocellular Carcinoma Patients without Liver Stiffness Evaluation
Atsushi Hiraoka, Fujimasa Tada, Hideko Ohama, et al.
Cancers
|
January 8, 2023
Clinical Usefulness of Surgical Resection Including the Complementary Use of Radiofrequency Ablation for Intermediate-Stage Hepatocellular Carcinoma
Hideko Ohama, Atsushi Hiraoka, Fujimasa Tada, et al.
Page
of 12
Search research articles
Search
Showing results (41-50 of 117) with videos related to
Sort By:
Page
of 12
Journal of Gastroenterology
|
November 15, 2024
Clinical factors to predict changes of esophagogastric varices after sustained viral response with direct-acting antiviral therapy
Takao Watanabe, Yoshio Tokumoto, Hironori Ochi, et al.
Scientific Reports
|
June 2, 2023
Simple new clinical score to predict hepatocellular carcinoma after sustained viral response with direct-acting antivirals
Takao Watanabe, Yoshio Tokumoto, Kouji Joko, et al.
Hepatology Communications
|
August 29, 2025
Carbon-ion radiotherapy achieves outcomes equivalent to surgical resection for hepatocellular carcinoma
Takeshi Hatanaka, Kei Shibuya, Satoru Kakizaki, et al.
Cancers
|
November 26, 2022
Comparison of Surgical Resection and Percutaneous Ultrasonographic Guided Radiofrequency Ablation for Initial Recurrence of Hepatocellular Carcinoma in Early Stage following Curative Treatment
Hideko Ohama, Atsushi Hiraoka, Fujimasa Tada, et al.
Oncology
|
July 17, 2023
Usefulness of aMAP Risk Score for Predicting Recurrence after Curative Treatment for Hepatocellular Carcinoma within Milan Criteria
Hideko Ohama, Atsushi Hiraoka, Fujimasa Tada, et al.
BMC Gastroenterology
|
November 14, 2025
Factors associated with ulcerative colitis with non-anemic iron deficiency
Shogo Kitahata, Mai Fukumoto, Kana Matsuoka, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology
|
September 23, 2022
The beneficial impact of metabolic dysfunction-associated fatty liver disease on lenvatinib treatment in patients with non-viral hepatocellular carcinoma
Shigeo Shimose, Atsushi Hiraoka, Andrea Casadei-Gardini, et al.
Oncology
|
August 20, 2024
Factors Affecting an Increase in Spleen Volume and Association of Spleen Volume Variation with the Clinical Outcomes of Atezolizumab and Bevacizumab Treatment for Hepatocellular Carcinoma: A Retrospective Analysis
Takeshi Hatanaka, Naoto Saito, Satoru Kakizaki, et al.
Oncology
|
October 11, 2023
Simple Scoring System for Esophagogastric Varices Prediction in Hepatocellular Carcinoma Patients without Liver Stiffness Evaluation
Atsushi Hiraoka, Fujimasa Tada, Hideko Ohama, et al.
Cancers
|
January 8, 2023
Clinical Usefulness of Surgical Resection Including the Complementary Use of Radiofrequency Ablation for Intermediate-Stage Hepatocellular Carcinoma
Hideko Ohama, Atsushi Hiraoka, Fujimasa Tada, et al.
Page
of 12